Max Financial: consolidated PAT up 37% YoY to ₹118 Cr as insurance segment profit jumps 40%

Max Financial Services' consolidated (primary basis) PAT came in at ₹118.29 Cr for Q1 FY27, up 36.8% year-on-year from ₹86.45 Cr, on revenue from operations of ₹14,969.51 Cr, up 16.8% YoY from ₹12,821.65 Cr. On a sequential basis the print is a turnaround from Q4 FY26's ₹31.52 Cr loss (revenue ₹10,801.94 Cr) — but that comparison is a seasonality/mark-to-market artifact rather than the headline story, since YoY is the primary read here and both periods were profitable. Net premium income from the life insurance business was ₹7,275.42 Cr, up 18.2% YoY (₹6,156.38 Cr), broadly consistent with management's own press release claiming 17% YoY growth in Individual Adjusted First Year Premium and an improved private market share of 10.1%. The margin bridge sits mainly in investment/fair-value swings and the life insurance segment. Consolidated PBT was ₹137.92 Cr versus ₹101.48 Cr YoY (+35.9%) and versus a ₹38.07 Cr loss in Q4 FY26; net gain on fair value changes flipped from a ₹93.59 Cr loss last quarter to a ₹47.44 Cr gain this quarter (versus ₹35.57 Cr a year ago), and this line is the single biggest swing factor in the QoQ turnaround. Net profit margin improved to 0.79% of total income from 0.67% a year ago and from a negative 0.29% loss margin last quarter. By segment, Life Insurance (Axis Max Life) delivered a PBT of ₹168.24 Cr, up 40.3% YoY from ₹119.95 Cr and a swing from a ₹2.68 Cr segment loss in Q4 FY26; Business Investments stayed a small loss (₹1.89 Cr) roughly flat with the ₹2.04 Cr loss a year ago. A web search for Street/consensus estimates on this print did not turn up an explicit PAT or revenue consensus figure — pre-result previews (e.g., niftytrader) instead flagged Value of New Business (VNB) margin and AUM growth as the metrics investors would watch, and this filing (financial statements plus notes only) does not disclose VNB margin, so that watch item remains unresolved pending the investor presentation/concall. On guidance, management's most recent stated target — a 24-25% VNB margin for FY26, reinforced in the February 2026 concall — was specific to the fiscal year that has since closed and is not directly re-tested by this Q1 FY27 filing; no fresh FY27 guidance appears in the statement itself, so this print cannot be graded against a live numeric target from this document alone. Corporate developments this quarter were largely non-P&L: the long-pending SEBI show-cause notice against the company and AMLI (over historical AMLI share transactions) remains open with no impact reflected in these results, a ₹4,720 penalty was levied for an NRC compliance lapse, and post-quarter-end the subsidiary received GST show-cause notices totaling ₹35.29 Cr (Aug 8) while redeeming a ₹496 Cr NCD tranche (Aug 4) and making a ₹5,329 Cr debenture payment (Aug 1); the proposed amalgamation of Axis Max Life and MFSL continues to progress through regulatory and shareholder approvals per the notes to accounts. Standalone (holding-company-only) numbers are secondary and small in scale — PAT of ₹0.73 Cr on total income of ₹5.64 Cr, down from ₹10.17 Cr in Q4 FY26, though that prior quarter benefited from a one-off ₹14.02 Cr dividend from AMLI that did not recur this quarter; standalone and consolidated tell consistent directional stories once that one-off is excluded. Overall this sets up the next checkpoint around VNB margin, persistency, and any formal FY27 guidance reset at the investor call.